###begin article-title 0
Association analysis of peroxisome proliferator-activated receptors gamma gene polymorphisms with asprin hypersensitivity in asthmatics
###end article-title 0
###begin title 1
Purpose
###end title 1
###begin p 2
###xml 431 436 427 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 484 489 480 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 655 660 651 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
Peroxisome proliferator-activated receptors (PPARs) are transcriptional factors activated by ligands of the nuclear hormone receptor superfamily. The activation of PPARgamma regulates inflammation by downregulating the production of Th2 type cytokines and eosinophil function. In addition, a range of natural substances, including arachidonate pathway metabolites such as 15-hydroxyeicosatetranoic acid (15-HETE), strongly promote PPARG expression. Therefore, genetic variants of the PPARG gene may be associated with the development of aspirin-intolerant asthma (AIA). We investigated the relationship between single nucleotide polymorphism (SNP) of the PPARG gene and AIA.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 132 133 132 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 263 268 263 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 327 332 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">34C&gt;G</italic>
###xml 349 357 349 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">82466C&gt;T</italic>
Based on the results of an oral aspirin challenge, asthmatics (n=403) were categorized into two groups: those with a decrease in FEV1 of 15% or greater (AIA) or less than 15% (aspirin-tolerant asthma, ATA). We genotyped two single nucleotide polymorphisms in the PPARG gene from Korean asthmatics and normal controls (n=449): +34C>G (Pro12Ala) and +82466C>T (His449His).
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 42 50 42 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">82466C&gt;T</italic>
###xml 152 153 152 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 198 206 198 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">82466C&gt;T</italic>
###xml 293 294 293 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 354 359 354 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 465 466 465 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 239 247 <span type="species:ncbi:9606">patients</span>
###xml 260 268 <span type="species:ncbi:9606">patients</span>
###xml 403 411 <span type="species:ncbi:9606">patients</span>
###xml 424 432 <span type="species:ncbi:9606">patients</span>
Logistic regression analysis showed that +82466C>T and haplotype 1 (CC) were associated with the development of aspirin hypersensitivity in asthmatics (P=0.04). The frequency of the rare allele of +82466C>T was significantly higher in AIA patients than in ATA patients in the recessive model [P=0.04, OR=3.97 (1.08-14.53)]. In addition, the frequency of PPARG haplotype 1 was significantly lower in AIA patients than in ATA patients in the dominant model (OR=0.25, P=0.04).
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 5 13 5 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">82466C&gt;T</italic>
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
The +82466C>T polymorphism and haplotype 1 of the PPARG gene may be linked to increased risk for aspirin hypersensitivity in asthma.
###end p 8
###begin title 9
INTRODUCTION
###end title 9
###begin p 10
###xml 281 282 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 365 370 357 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 427 432 412 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 560 561 545 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 587 588 572 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 713 718 698 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 928 933 913 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 945 946 930 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 947 948 932 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 968 973 953 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 1047 1048 1032 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1048 1053 1033 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 1150 1151 1135 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
Peroxisome proliferator-activated receptors (PPARs) are transcriptional factors activated by ligands of the nuclear hormone receptor superfamily. This superfamily is divided into the steroid receptor family and the thyroid, vitamin D, and retinoid (or non-steroid) receptor family.1 Three different PPAR subtypes have been identified: PPARalpha (PPARA), PPARgamma (PPARG), and PPARdelta (PPARD, which is also called PPARbeta). PPARG (MIM #601487), located on chromosome 3p25, plays an important role in regulating adipocyte differentiation and lipid metabolism2 as well as cell turnover.3 However, the production of immune-modulating cytokines in various cell types was reported to downregulate the expression of PPARG, and block adipocyte differentiation. It is well established that a variety of natural substances, including arachidonate pathway metabolites such as 15-hydroxyeicosatetranoic acid (15-HETE), strongly promote PPARG expression.3-5 Stimulation of the PPARG ligand significantly inhibited the downregulation of eosinophil function.6PPARG expression is associated with the inflammatory and remodeling responses in the asthmatic airway.7
###end p 10
###begin p 11
###xml 346 347 346 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 510 511 510 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 741 743 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1045 1047 1045 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1248 1250 1248 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1251 1253 1251 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1345 1350 1345 1350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 1387 1392 1387 1392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 571 579 <span type="species:ncbi:9606">patients</span>
Among the sub-phenotypes of asthma, aspirin-intolerant asthma (AIA) refers to the development of bronchoconstriction in asthmatic individuals following the ingestion of aspirin or other non-steroidal anti-inflammatory drugs. This syndrome is characterized by the 'aspirin triad' of aspirin hypersensitivity, bronchial asthma, and nasal polyposis.8 Most clinical investigators now include chronic hyperplastic eosinophilic sinusitis (CHES) as a fourth hallmark of aspirin-exacerbated respiratory disease (AERD).9 As is true for other asthmatic individuals, the airways of patients with AIA show signs of persistent inflammation, with marked eosinophilia, epithelial disruption, cytokine production, and upregulation of inflammatory molecules.10 Although the pathogenesis of AIA has not been elucidated completely, multiple points of overproduction or underproduction of critical mediators in the metabolism of arachidonic acid, including leukotrienes, lipoxins, thromboxane, and prostaglandins, probably account for the susceptibility to aspirin.10 In addition, the levels of proinflammatory, immune cytokines and chemokines, including IL-2, IL-3, IL-4, IL-5, IL-13, GM-CSF, and eotaxin, are increased in the airways and systemic circulation in AIA.11,12 The production of these molecules is regulated by various transcription factors, including PPARG. Therefore, genetic variants of the PPARG gene may be associated with the development of asthma or aspirin intolerance in asthmatics.
###end p 11
###begin p 12
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 205 210 205 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">34C&gt;G</italic>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 402 407 402 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 415 420 415 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">34C&gt;G</italic>
###xml 437 445 437 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">82466C&gt;T</italic>
Recently, Palmer et al. reported that PPARG gene polymorphisms are associated with a risk for asthma exacerbation in Caucasian populations.13 We also reported that the homozygous haplotype combination of +34C>G (Pro12Ala) was associated with an increased risk for asthma exacerbation.13 To our knowledge, however, no study has analyzed the potential associations of the two common polymorphisms of the PPARG gene [+34C>G (Pro12Ala) and +82466C>T (His449His)] with the risk for aspirin intolerance in asthmatics.
###end p 12
###begin title 13
MATERIALS AND METHODS
###end title 13
###begin title 14
Subjects
###end title 14
###begin p 15
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 612 613 612 613 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 713 715 713 715 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 756 757 756 757 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1113 1114 1113 1114 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1411 1413 1411 1413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1414 1416 1414 1416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1486 1487 1486 1487 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1578 1579 1578 1579 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1619 1620 1619 1620 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1904 1906 1904 1906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1976 1977 1976 1977 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 2003 2005 2003 2005 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 2406 2411 2406 2411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 2507 2509 2507 2509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 261 268 <span type="species:ncbi:9606">patient</span>
###xml 485 493 <span type="species:ncbi:9606">patients</span>
###xml 1774 1782 <span type="species:ncbi:9606">patients</span>
The subjects were recruited from the Asthma Genome Research Center, comprising Soonchunhyang Bucheon, Seoul, and Chunan Hospitals, and Chunnam and Chungbuk University Hospitals in Korea. All of the subjects were Korean. A clinical history was obtained for each patient, using a physician-administered questionnaire that included the history of aspirin hypersensitivity. The asthmatics had compatible clinical symptoms and physical characteristics (Global Initiative for Asthma).14 All patients had a history of dyspnea and wheezing during the previous 12 months plus one of the following: 1) >15% increase in FEV1 or >12% increase plus 200 mL following inhalation of a short-acting bronchodilator; 2) <10 mg/mL PC20 methacholine; or 3) >20% increase in FEV1 following 2 weeks of treatment with inhaled steroids and long-acting bronchodilators. The asthmatics had experienced no exacerbation of asthma or any respiratory tract infection in the 6 weeks preceding the oral aspirin challenge (OAC). Based on the results of the OAC, the asthmatics (n=403) were categorized into two groups: those with a decrease in FEV1 of 15% or greater (AIA, n=60), and those with a decrease of less than 15% [aspirin-tolerant asthma (ATA), n=343]. The oral provocation test was performed with increasing doses of aspirin (10-450 mg Astrix; Mayne Pharma, Melbourne, Australia) using a modification of a previously described method.15,16 Aspirin-intolerance bronchospasm, as reflected by the rate (%) of FEV1 decline, was calculated as the difference between the pre-challenge and post-challenge FEV1 values divided by the pre-challenge FEV1. Subjects who developed skin manifestations were labeled as positive responders (n=60). Normal controls (n=449) were recruited from among spouses of the patients or members of the general population who answered negatively to a screening questionnaire regarding respiratory symptoms.17 The normal controls had no history of aspirin intolerance and had FEV1 values >80% predicted, PC20 methacholine >10 mg/mL, and normal findings on simple chest radiograms. Skin prick tests were performed with 24 common aeroallergens (Bencard, Brentford, UK). Atopy was defined as one or more positive reactions (>3 mm in diameter) on the skin prick test. Total IgE was measured using a UniCAP system (Pharmacia Diagnostics, Uppsala, Sweden). Subjects with diabetes mellitus were excluded because the PPARG polymorphism is reported to be associated with the development of diabetes mellitus in Koreans.18 All subjects gave written informed consent to participate in the study, and the protocol was approved by the local ethics committees.
###end p 15
###begin title 16
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
Genotyping the SNPs in the PPARG gene
###end title 16
###begin p 17
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
The amplifying primers and probes used to genotype the polymorphic sites by the single base method were as described previously.19 Primer Express (Applied Biosystems, Foster City, CA, USA) was used to design the PCR primers and MGB TaqMan probes. One allelic probe was labeled with FAM dye; and the other, with fluorescent VIC dye. PCR was performed in TaqMan Universal Master Mix, without uracil-N-glycosylase (Applied Biosystems), containing 900 nM TaqMan MGB-probe and 200 nM primer. The reaction was performed in a 384-well plate in a total reaction volume of 5 microL, using 20 ng of genomic DNA. The plate was heated in a thermal cycler (PE 9700; Applied Biosystems) for 2 min at 50℃ and then for 10 min at 95℃, followed by 40 cycles of 95℃ for 15 s and 60℃ for 1 min. The fluorescence intensity of each reaction was determined using a Prism 7900 HT detector (Applied Biosystems), and the fluorescence data were analyzed by automated software (SDS 2.1).
###end p 17
###begin title 18
Statistical analysis
###end title 18
###begin p 19
###xml 53 54 53 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 52 54 52 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R<sup>2</sup></italic>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 467 472 467 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 916 917 916 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
We applied the widely used Lewontin's D' (|D'|) and R2 measures of linkage disequilibrium to all pairs of biallelic loci.20 Haplotype associations were estimated using HaploScore (), which computes score statistics to test for associations between a given haplotype and a wide variety of traits, including binary, ordinal, quantitative, and Poisson parameters. The genetic effects of the haplotypes were analyzed in the same way as the SNPs. The distributions of the PPARG SNP genotypes and haplotypes among the subjects with asthma and the normal subjects were analyzed with logistic regression models that controlled for age (continuous value), gender (male=0, female=1), atopy status (non-atopy=0, atopy=1), body mass index (BMI; continuous value), and smoking status (nonsmoker=0, ex-smoker=1, smoker=2) as covariates. The data were managed and analyzed using SPSS ver. 10.0 (SPSS, Chicago, IL, USA). A value of P</=0.05 was regarded as statistically significant.
###end p 19
###begin title 20
RESULTS
###end title 20
###begin title 21
Characteristics of the study subjects
###end title 21
###begin p 22
###xml 119 126 119 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 151 152 151 152 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 267 268 267 268 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 301 302 301 302 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 350 352 350 352 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 465 466 465 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 474 481 474 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
We recruited 403 subjects from the asthma cohort. The clinical characteristics of the study subjects are summarized in Table 1. The maximum fall in FEV1 during the 5-hr follow-up period after aspirin challenge was used as the value for the aspirin-induced fall in FEV1. Aspirin-induced declines in FEV1 ranged from -15% to 68%. The log transformed PC20 methacholine values for the asthmatics were significantly lower among those with AIA than among those with ATA (P=0.013, Table 1).
###end p 22
###begin title 23
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
PPARG polymorphisms and the risk for aspirin intolerance in asthmatics
###end title 23
###begin p 24
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">34C&gt;G</italic>
###xml 39 47 39 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">82466C&gt;T</italic>
###xml 74 79 74 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 219 224 219 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">34C&gt;G</italic>
###xml 238 246 238 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">82466C&gt;T</italic>
###xml 249 256 249 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 355 356 355 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 363 370 363 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 554 557 554 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ht1</italic>
###xml 562 565 562 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ht2</italic>
###xml 655 662 655 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 692 697 692 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 698 706 698 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">82466C&gt;T</italic>
###xml 832 837 832 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 838 846 838 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">82466C&gt;T</italic>
###xml 927 928 927 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1016 1019 1016 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ht1</italic>
###xml 1079 1080 1079 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1150 1151 1150 1151 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1362 1370 1362 1370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">82466C&gt;T</italic>
###xml 1412 1413 1412 1413 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1460 1468 1460 1468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">82466C&gt;T</italic>
###xml 1526 1527 1526 1527 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1615 1623 1615 1623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">82466C&gt;T</italic>
###xml 1659 1660 1659 1660 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1722 1723 1722 1723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1732 1739 1732 1739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1A</xref>
###xml 1787 1788 1787 1788 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1853 1856 1853 1856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ht1</italic>
###xml 1901 1902 1901 1902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1911 1918 1911 1918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1B</xref>
Two SNPs, +34C>G (P12A) on exon 3 and +82466C>T (H449H) on exon 8, in the PPARG gene were genotyped for the association study. The minor allele frequencies (MAFs) of these two SNPs in the Korean population were 0.042 (+34C>G) and 0.168 (+82466C>T) (Table 2). The genotype distributions of the two SNPs were in Hardy-Weinberg equilibrium for all subjects (P>0.05, Table 2). Four haplotypes were constructed, and two haplotypes with a frequency >0.05 were used for the analysis. Using multiple logistic regression models, both SNPs and the two haplotypes (ht1 and ht2) were analyzed for associations with the risk for aspirin intolerance in the asthmatics (Table 3). The analysis revealed that PPARG+82466C>T was associated with aspirin intolerance in the recessive model, and there were more subjects homozygous for the rare alleles PPARG+82466C>T in the AIA group than in the ATA group in the recessive model (6.66% vs. 2.04%, P=0.04, OR=3.97 [1.08-14.53]). In the haplotype analysis, there were fewer subjects with ht1 in the AIA group than in the ATA group (93.33% vs. 97.96%, P=0.04, OR=0.25 [0.07-0.92]) in the dominant model. The rate (%) of FEV1 decline after aspirin challenge is the most important parameter for the diagnosis of aspirin intolerant asthmatics, and thus we used linear regression analysis to investigate the associations between the SNP (+82466C>T), haplotype 1, and percentage fall of FEV1 following aspirin challenge. Haplotype 1 and +82466C>T showed the strongest association with the rate (%) of FEV1 decline after aspirin challenge in the asthmatics. Asthmatics homozygous for the rare +82466C>T allele had a greater decline in FEV1 after aspirin provocation than those with the common allele (P=0.0004, Fig. 1A). In the haplotype analysis, the decline in FEV1 after aspirin provocation was greater in asthmatics lacking the ht1 haplotype than in those with the haplotype (P=0.0004, Fig. 1B).
###end p 24
###begin title 25
DISCUSSION
###end title 25
###begin p 26
###xml 80 81 80 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 168 169 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 204 209 204 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 324 329 324 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 459 461 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 483 485 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
PPARs are receptors for steroids, thyroid hormone, vitamin D, and retinoic acid,1 and they regulate adipocyte differentiation, lipid metabolism,2 and cellular turnover.3 Furthermore, polymorphisms of the PPARG gene have been associated with diabetes, obesity, and metabolic syndrome.18,21-25 The two common polymorphisms of PPARG were reported to modify susceptibility to type II diabetes mellitus, obesity, and sub-phenotypes of metabolic syndrome in Koreans18,21,22 and Caucasians.23-26 Therefore, we excluded subjects with diabetes from the analysis and adjusted the results for the BMI.
###end p 26
###begin p 27
###xml 205 206 205 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 255 260 255 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 261 269 261 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">82466C&gt;T</italic>
###xml 360 365 360 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 366 374 366 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">82466C&gt;T</italic>
###xml 429 436 429 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 511 514 511 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ht1</italic>
###xml 610 611 610 611 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 675 683 675 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">82466C&gt;T</italic>
###xml 793 794 793 794 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 859 862 859 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ht1</italic>
###xml 941 946 941 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 947 955 947 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">82466C&gt;T</italic>
In addition to their metabolic effects, PPARs/RXRs heterodimerize with various receptors, and these heterodimers regulate the transcription of genes involved in allergic inflammation and airway remodeling.7 A notable finding in our study was that the SNP PPARG+82466C>T was associated with aspirin intolerance. There were more subjects homozygous for the rare PPARG+82466C>T allele with AIA than with ATA in the recessive model (Table 3). In the haplotype analysis, there were significantly fewer subjects with ht1 in the AIA group than in the ATA group. Based on linear regression analysis, the decline in FEV1 after aspirin challenge in asthmatics homozygous for the rare +82466C>T allele was 2.5 times that in asthmatics with the common allele. In the haplotype analysis, the decline in FEV1 after aspirin provocation was greater in asthmatics without the ht1 haplotype than in those with the haplotype. These results suggest that a rare PPARG+82466C>T allele and haplotype 1 are predisposing factors for aspirin intolerance in asthmatics.
###end p 27
###begin p 28
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 320 325 320 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 490 495 490 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 717 722 717 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 780 785 780 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 1028 1033 1028 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 1168 1170 1168 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1676 1678 1676 1678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 1723 1728 1723 1728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 1729 1737 1729 1737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">82466C&gt;T</italic>
###xml 1972 1977 1972 1977 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 1978 1986 1978 1986 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">82466C&gt;T</italic>
###xml 2192 2197 2192 2197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 289 297 <span type="species:ncbi:9606">patients</span>
###xml 1667 1675 <span type="species:ncbi:9606">patients</span>
Some eicosanoids activate PPARG; these include 13-hydroxyoctadecadienoic acid,27 15-hydroxyeicosatetraenoic acid (15-HETE), and 15-deoxy-12,14 prostaglandinJ2 (15d-PGJ 2),28 a prostaglandin D2 metabolite. The accumulation of 15-HETE after aspirin-stimulation of peripheral leukocytes from patients with AIA may activate PPARG to modulate airway inflammation.29 As metabolites of the arachidonate pathway, such as 15-HETE and 15d-PGJ 2, regulate transcription and endogenous ligands for the PPARG gene, changes in these mediators in AIA may be responsible for the change in the amount of PPAR-r in the target organ of aspirin hypersensitivity. Therefore, altered synthesis of 15-HETE and 15d-PGJ 2 in AIA may activate PPARG differently from the activation in ATA. In addition, the PPARG agonist rosiglitazone upregulates both the mRNA expression of two lipoxygenase enzymes (platelet-type 12-lipoxygenase and 15-lipoxygenase) and the secretion of their eicosanoid products, 12- and 15-HETE. The rosiglitazone-induced increase in PPARG mRNA expression is blocked entirely by the lipoxygenase (LO) inhibitor baicalein and is restored by the addition of exogenous 12-HETE.30 In the process of lipoxin formation, aspirin acetylation does not totally inhibit the catalysis of COX-2, and this can affect the production of 12-HETE, 15-HETE, and 13-HODE. Previously, we observed that the alleles of the ALOX5 and ALOX5AP promoters cannot be considered prominent risk factors for the development of AIA. However, a genetic variant involving a tandem repeat (GGGCGG; Sp1-binding motif) in the ALOX5 promoter is associated with the severity of airway hyper-responsiveness in AIA patients.31 Therefore, genetic polymorphism of the rare PPARG+82466C>T allele may contribute to the development of aspirin intolerance via a functional change in the gene, such as an altered response to the LO products or altered induction of the two LO enzymes. The molecular mechanism by which the rare PPARG+82466C>T allele, which does not change the encoded protein, modulates the phenotype is even less clear. It is possible that these variants are in linkage disequilibrium with other functional variants, although the PPARG locus has been the focus of intense scrutiny as a candidate for diabetes and related traits, and no such variant has been found.
###end p 28
###begin p 29
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">34C&gt;G</italic>
###xml 76 84 76 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">82466C&gt;T</italic>
###xml 227 232 227 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 233 241 233 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">82466C&gt;T</italic>
###xml 246 251 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 340 348 340 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">82466C&gt;T</italic>
###xml 390 395 390 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 695 700 695 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 832 837 832 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
In summary, we genotyped two SNPs in the PPARG gene, +34C>G (Pro12Ala) and +82466C>T (His449His), and examined the association of each with the development of aspirin intolerance in asthmatics. Association analysis showed that PPARG+82466C>T and PPARG haplotypes were associated with the development of aspirin intolerance. Therefore, the +82466C>T polymorphism in the coding region of the PPARG gene may confer aspirin hypersensitivity via the regulation of gene expression. This information may be useful in the development of new strategies for the diagnosis and control of aspirin intolerance. Further studies are required to define the molecular mechanisms by which common variation at the PPARG locus modulates aspirin hypersensitivity, and to determine whether this suggests treatment strategies in asthmatics with different PPARG genotypes.
###end p 29
###begin title 30
ACKNOWLEDGMENTS
###end title 30
###begin p 31
###xml 44 71 44 71 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Korea Health 21 R&amp;D Project</funding-source>
###xml 74 81 74 81 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A010249</award-id>
###xml 247 313 247 313 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ministry of Health, Welfare, and Family Affairs, Republic of Korea</funding-source>
This work was supported by a grant from the Korea Health 21 R&D Project, (A010249), and the DNA samples were generously provided by the Soonchunhyang University Bucheon Hospital Biobank, a member of the National Biobank of Korea, supported by the Ministry of Health, Welfare, and Family Affairs, Republic of Korea.
###end p 31
###begin p 32
There are no financial or other issues that might lead to conflict of interest.
###end p 32
###begin article-title 33
The nuclear receptor superfamily: the second decade
###end article-title 33
###begin article-title 34
Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor
###end article-title 34
###begin article-title 35
###xml 84 89 <span type="species:ncbi:9606">human</span>
Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages
###end article-title 35
###begin article-title 36
PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines
###end article-title 36
###begin article-title 37
Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase
###end article-title 37
###begin article-title 38
Peroxisome proliferator-activated receptor gamma regulates eosinophil functions: a new therapeutic target for allergic airway inflammation
###end article-title 38
###begin article-title 39
###xml 77 82 <span type="species:ncbi:9606">human</span>
Regulation of peroxisome proliferator-activated receptor gamma expression in human asthmatic airways: relationship with proliferation, apoptosis, and airway remodeling
###end article-title 39
###begin article-title 40
Concerning the nature of intolerance to aspirin
###end article-title 40
###begin article-title 41
Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes
###end article-title 41
###begin article-title 42
Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management
###end article-title 42
###begin article-title 43
###xml 33 38 <span type="species:ncbi:9606">human</span>
IL-5 synthesis is upregulated in human nasal polyp tissue
###end article-title 43
###begin article-title 44
###xml 89 97 <span type="species:ncbi:9606">patients</span>
Comparison of plasma eotaxin family level in aspirin-induced and aspirin-tolerant asthma patients
###end article-title 44
###begin article-title 45
PPARG locus haplotype variation and exacerbations in asthma
###end article-title 45
###begin article-title 46
Expert panel report: guidelines for the diagnosis and management of asthma update on selected topics
###end article-title 46
###begin article-title 47
Association of angiotensin I-converting enzyme gene polymorphisms with aspirin intolerance in asthmatics
###end article-title 47
###begin article-title 48
Improvements in an oral aspirin challenge protocol for the diagnosis of aspirin hypersensitivity
###end article-title 48
###begin article-title 49
Epidemiology Standardization Project (American Thoracic Society)
###end article-title 49
###begin article-title 50
Genetic polymorphisms in peroxisome proliferator-activated receptor gamma are associated with Type 2 diabetes mellitus and obesity in the Korean population
###end article-title 50
###begin article-title 51
Association of peroxisome proliferator-activated receptor-gamma gene polymorphisms with the development of asthma
###end article-title 51
###begin article-title 52
Gametic disequilibrium measures: proceed with caution
###end article-title 52
###begin article-title 53
Effects of peroxisome proliferator-activated receptor-gamma 2 Pro12Ala polymorphism on body fat distribution in female Korean subjects
###end article-title 53
###begin article-title 54
Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome
###end article-title 54
###begin article-title 55
Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes
###end article-title 55
###begin article-title 56
The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
###end article-title 56
###begin article-title 57
Testing for population subdivision and association in four case-control studies
###end article-title 57
###begin article-title 58
The common PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity
###end article-title 58
###begin article-title 59
Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma
###end article-title 59
###begin article-title 60
15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma
###end article-title 60
###begin article-title 61
###xml 141 149 <span type="species:ncbi:9606">patients</span>
Differential effects of aspirin and misoprostol on 15-hydroxyeicosatetraenoic acid generation by leukocytes from aspirin-sensitive asthmatic patients
###end article-title 61
###begin article-title 62
###xml 116 121 <span type="species:ncbi:9606">human</span>
Lipoxygenase-derived metabolites are regulators of peroxisome proliferator-activated receptor gamma-2 expression in human vascular smooth muscle cells
###end article-title 62
###begin article-title 63
Polymorphism of tandem repeat in promoter of 5-lipoxygenase in ASA-intolerant asthma: a positive association with airway hyperresponsiveness
###end article-title 63
###begin p 64
###xml 45 46 45 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 136 144 136 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">82466C&gt;T</italic>
###xml 168 173 168 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 184 185 184 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The comparison of the rate of fall (%) of FEV1 with aspirin provocation between subjects possessing the rare and common alleles by (A) +82466C>T and (B) haplotype 1 of PPARG gene. The P values were obtained by linear regression analysis, controlled for age (continuous value), gender (male=0, female=1), atopy status (non-atopy=0, atopy=1), smoking status (non-smoker=0, ex-smoker=1, smoker=2), and BMI (continuous value) as covariates.
###end p 64
###begin p 65
The clinical profiles of the study subjects
###end p 65
###begin p 66
Values are mean+/-S.E. ATA and AIA represent aspirin-tolerant asthma and aspirin-intolerant asthma, respectively.
###end p 66
###begin p 67
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 41 42 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
P values are obtained using T test or chi2 test between AIA and ATA.
###end p 67
###begin p 68
###xml 71 76 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
The frequencies, heterozygosity and Hardy-Weinberg Equation of SNPs on PPARG gene in the study population
###end p 68
###begin p 69
C/C, C/R and C/C represent common allele, heterozygosity and rare allele.
###end p 69
###begin p 70
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
*P values of deviation from Hardy-Weinberg Equilibrium in the study population.
###end p 70
###begin p 71
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
Comparisons of genotype and haplotype distributions of PPARG between the subjects with AIA and the subjects with ATA
###end p 71
###begin p 72
###xml 169 170 169 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
ATA and AIA represent aspirin-tolerant asthma and aspirin-intolerant asthma, respectively. C/C, C/R and R/R represent common allele, heterozygosity and rare allele. The P values were obtained by logistic regression analysis, controlled for age (continuous value), sex (male=0, female=1), atopy status (non-atopy=0, atopy=1) and smoking status (non-smoker=0, ex-smoker=1, smoker=2) and BMI (continuous value) as co-variables.
###end p 72
###begin p 73
###xml 20 21 20 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Bold faces mean the P<0.05.
###end p 73

